April 8, 2026 · Form 4 insider transaction
Yeleswaram Krishnaswamy sold 360 shares of Rapport Therapeutics, Inc. at $34.90 per share, a transaction worth $12.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025.